{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:32:56Z","timestamp":1740144776533,"version":"3.37.3"},"reference-count":5,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.2337\/dc20-0993","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:40:53Z","timestamp":1600735253000},"page":"e157-e158","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015\u20132018. Diabetes Care 2020;43:244\u2013246"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8374-4026","authenticated-orcid":false,"given":"Kerstin","family":"Brand","sequence":"first","affiliation":[{"name":"Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"2022031223583866900_B1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/dc19-0923","article-title":"Reports of lactic acidosis attributed to metformin, 2015\u20132018","volume":"43","author":"Flory","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031223583866900_B2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12882-018-0875-8","article-title":"Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up","volume":"19","author":"Angioi","year":"2018","journal-title":"BMC Nephrol"},{"key":"2022031223583866900_B3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jamia\/ocv063","article-title":"Use of data mining at the Food and Drug Administration","volume":"23","author":"Duggirala","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"2022031223583866900_B4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0140-6736(16)31583-5","article-title":"Offline: lessons from the controversy over statins","volume":"388","author":"Horton","year":"2016","journal-title":"Lancet"},{"key":"2022031223583866900_B5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacl.2016.05.002","article-title":"The nocebo effect in the context of statin intolerance","volume":"10","author":"Tobert","year":"2016","journal-title":"J Clin Lipidol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/10\/e157\/630703\/dc200993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/10\/e157\/630703\/dc200993.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:50:54Z","timestamp":1647143454000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/10\/e157\/35980\/Comment-on-Flory-et-al-Reports-of-Lactic-Acidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":5,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,11]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc20-0993","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"type":"print","value":"0149-5992"},{"type":"electronic","value":"1935-5548"}],"subject":[],"published":{"date-parts":[[2020,9,11]]}}}